4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000173
Director sold 400 shares at $505.86 ($202,344)
- Director acquired 796 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Bhatia Sangeeta N. · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-05-01 | Grant or award : show line 1 in the form 10b5-1 | +796 | 5,231 | D | ||
| 2025-05-02 | Sale : show line 2 in the form 10b5-1 | −400 | $505.86 | $202,344 | 4,831 | D |
| Open-market sales · 400 sh · avg $505.86 · $202,344 | ||||||
Loading xslF345X05/wk-form4_1746476052.xml…